Market Overview:

The market for nuclear medicine diagnostics is expected to be USD 10.81 billion in 2018 and is estimated to reach USD 19.43 billion by the end of 2023. Throughout this period of forecast, the market is estimated to grow at a CAGR of 12.45%. Nuclear medicine is a branch of medicine that uses radiation to deliver information about the functioning of a person’s specific organs or to treat a disease. In most cases, the information will assist the physicians to make a rapid, accurate diagnosis of the patient’s illness. Over 10,000 hospitals worldwide practice radioisotopes in medicine, and about 90% of these procedures are for diagnosis.

Market drivers and restraints:

The increasing incidence and prevalence of cancer and cardiovascular diseases (CVD) will be the major factor supporting market growth. Most cases can be prevented through early detection and treatment; nuclear medicine plays a major role in these areas. According to GLOBOCAN 2012, the global incidence of cancer was 14.1 million (excluding non-melanoma skin cancer) in 2012. In addition, annually 19.3 million new cases are expected to be detected by 2025. By driving the overall use and need for nuclear medicine, the growing incidence and prevalence are estimated to directly affect market growth.

To know more, click on the link below:

https://www.marketdataforecast.com/market-reports/nuclear-medicine-diagnostics-market

Report segmented as:

By type:

Technetium-99m (TC-99m)
Thallium-201 (TL-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (RB-82)
others
By application:

cardiology
lymphoma
thyroid
neurology oncology
others
Geographical analysis:

On the basis of geography, the market is segregated into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America accounts for the biggest share of the nuclear medicine market, followed by Asia Pacific and Europe.

Important market players:

The key players operating in the global nuclear medicine diagnostics market are Cardinal Health, Inc., Bracco Imaging S.p.A, GE Healthcare, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc., Advanced Accelerator Applications S.A., IBA Molecular Imaging, and Mallinckrodt plc.

View a sample and decide @ https://www.marketdataforecast.com/market-reports/nuclear-medicine-diagnostics-market/request-sample

The Scope of the report:

This report offers the current product and services market evaluation and the future estimation of the market. It helps us understand the market better through size anticipation and CAGR calculation to estimate the next market. It has a broader segmentation for better understanding of the enterprising of the market at a low level by segregating the market into smaller sectors.

Apart from the syndicated report, our in-house team has expertise and experience in designing custom reports to meet your specific research needs and assist you in making well-informed decisions.

About Us:

Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients.

For more information:

Abhishek Shukla

Sales Manager at Market Data Forecast

Email: [email protected]

Tel: +1-888-702-9626

Website: https://www.marketdataforecast.com/